Entera Bio Ltd Announces Interim Biomarker Data From Phase 2 Clinical Trial of EB613 and First Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
| Entrx Corporation (NASDAQ: ENTX) | Delayed: 3.05 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.05 | 52 Week High | $0.30 | |||
| Open | $3.05 | 52 Week Low | $0.10 | |||
| Day High | $3.05 | P/E | N/A | |||
| Day Low | $3.05 | EPS | $0.00 | |||
| Volume | 1,500 | |||||
